<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[NEC OncoImmunity 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=39892></link><description><![CDATA[NEC OncoImmunity 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Sat, 16 May 2026 05:23:52 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2022/02/12_3554238800_20220218085853_5465156884.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[NEC OncoImmunity Publishes a Unique HLA Typing Technology That Discovers New HLA Alleles, and Tumor Specific HLA Alleles]]></title><link>https://www.newswire.co.kr/newsRead.php?no=939741</link><description><![CDATA[OSLO, Norway--(Business Wire/Korea Newswire)--NEC OncoImmunity AS (NOI) today announced a publication that describes a novel approach to type new HLA alleles and characterize the HLA of tumors to guide personalized cancer immunotherapy.  The computational approach performs HLA typing from next generation sequencing data by using the current strengths of conventional HLA typing while simulta...]]></description><pubDate>Fri, 18 Feb 2022 09:10:00 +0900</pubDate></item><item><title><![CDATA[NEC 온코이뮤니티, 새로운 HLA 유전인자와 암 특이성 HLA 유전인자 발견 뒷받침하는 새로운 HLA 범주화 기술 공개]]></title><link>https://www.newswire.co.kr/newsRead.php?no=939742</link><description><![CDATA[오슬로, 노르웨이--(Business Wire/뉴스와이어)--NEC 온코이뮤니티 AS(NEC OncoImmunity AS, 이하 ‘NOI’)가 새로운 HLA(백혈구 항원) 유전인자를 분류하고 종양 HLA를 특징지어 맞춤형 암 면역 요법으로 인도할 새로운 접근법을 논문을 통해 공개했다고 17일 발표했다.   컴퓨터를 이용한 NOI의 새로운 접근법은 기존 HLA 범주화가 가진 장점을 십분 활용해 차세대 염기 서열 분석 데이터에서 HLA 범주화를 수행하며, 바이...]]></description><pubDate>Fri, 18 Feb 2022 09:10:00 +0900</pubDate></item></channel></rss>